title: Alterations in glucose and protein metabolism in animals subjected to simulated microgravity.
abstract: Reduction of physical activity due to disease or environmental restraints, such as total bed rest or exposure to spaceflight, leads to atrophy of skeletal muscle and is frequently accompanied by alterations in food intake and the concentration of metabolic regulatory hormones such as insulin.  Hindlimb suspension of laboratory rats, as a model for microgravity, also shows marked atrophy of gravity dependent muscles along with a reduced gain in body weight.  Suspended rats exhibit enhanced sensitivity to insulin-induced glucose uptake when compared with normal control rats and resistance to insulin action when compared with control rats matched similarly for reduced body weight gain.  These changes are accompanied by decreased insulin binding and tyrosine kinase activity in soleus but not plantaris muscle, unchanged glucose uptake by perfused hindlimb and decreased sensitivity but not responsiveness to insulin-induced suppression of net proteolysis in hindlimb skeletal muscle.  These findings suggest that loss of insulin sensitivity during muscle atrophy is associated with decreased insulin binding and tyrosine kinase activity in atrophied soleus muscle along with decreased sensitivity to the effects of insulin on suppressing net protein breakdown but not on enhancing glucose uptake by perfused hindlimb.
authors.affiliation: VA Medical Center, Geriatric Research, Education and Clinical Center, Palo Alto, CA 94304, USA.
authors.forename: C E
authors.initials: CE
authors.lastname: Mondon
authors.forename: K J
authors.initials: KJ
authors.lastname: Rodnick
authors.forename: C B
authors.initials: CB
authors.lastname: Dolkas
authors.forename: S
authors.initials: S
authors.lastname: Azhar
authors.forename: G M
authors.initials: GM
authors.lastname: Reaven
mesh_terms: D000818:Animals; D001835:Body Weight; D005947:Glucose / Q000378:metabolism*; D006003:Glycogen / Q000378:metabolism; D006614:Hindlimb; D007103:Immobilization / Q000009:adverse effects*; D007328:Insulin / Q000378:metabolism* / Q000502:physiology; D007333:Insulin Resistance / Q000502:physiology; D008099:Liver / Q000378:metabolism; D008112:Liver Glycogen / Q000378:metabolism; D008297:Male; D018482:Muscle, Skeletal / Q000502:physiology; D009133:Muscular Atrophy / Q000209:etiology / Q000378:metabolism; D011505:Protein-Tyrosine Kinases / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011972:Receptor, Insulin / Q000502:physiology*; D018474:Weightlessness Simulation
chemical_list: D007328:Insulin; D008112:Liver Glycogen; D006003:Glycogen; D011505:Protein-Tyrosine Kinases; D011972:Receptor, Insulin; D005947:Glucose